| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
2,475 |
1,353 |
$717K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,830 |
1,765 |
$587K |
| 92134 |
|
2,491 |
2,323 |
$439K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
3,351 |
2,093 |
$356K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
613 |
610 |
$53K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
29 |
20 |
$23K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15 |
15 |
$17K |
| J9035 |
Injection, bevacizumab, 10 mg |
256 |
221 |
$6K |
| 67515 |
|
101 |
79 |
$4K |
| 76512 |
|
106 |
61 |
$3K |
| 92202 |
|
396 |
386 |
$540.63 |
| 92081 |
|
152 |
152 |
$453.66 |
| 92250 |
|
126 |
126 |
$355.22 |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
17 |
17 |
$339.70 |
| 92201 |
|
37 |
37 |
$309.54 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
40 |
38 |
$171.42 |
| J7999 |
Compounded drug, not otherwise classified |
13 |
12 |
$83.20 |